Incorporated in 2012 with headquarter offices in Shanghaiand Beijing, China, Zhongchao Inc. is an online provider of healthcare information, professional training and educational services to healthcare professionals under its 'MDMOOC' platform (www.mdmooc.org) and to the public under its 'Sunshine Health Forums' platform (www.ygjkclass.com) in China. The Company also offers patient management services under its 'Zhongxun' platform (www.zhongxun.online).

Company profile
Ticker
ZCMD
Exchange
Website
CEO
Wei Guang Yang
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Zhongchao Group Inc. • Zhongchao USA LLC • Zhongchao Group Limited • Beijing Zhongchao Zhongxing Technology Limited • Zhongchao Medical Technology (Shanghai) Corp. • Shanghai Maidemu Cultural Communication Corp. • Shanghai Huijing Information Technology Co., Ltd. • Beijing Zhongchao Boya Medical Technology Co., Ltd. • Zhixun Internet Hospital (Liaoning) Co., Ltd. • Hainan Zhongteng Medical Technology Co., Ltd. ...
ZCMD stock data
Latest filings (excl ownership)
6-K
Report of Foreign Private Issuer
16 Dec 22
6-K
Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications
28 Sep 22
6-K
Report of Foreign Private Issuer
27 Sep 22
6-K
Report of Foreign Private Issuer
28 Jul 22
6-K
Notice of Annual General Meeting of Shareholders
14 Jun 22
20-F
2021 FY
Annual report (foreign)
9 May 22
NT 20-F
Notice of late annual filing (foreign)
2 May 22
6-K
Report of Foreign Private Issuer
17 Dec 21
424B5
Prospectus supplement for primary offering
17 Dec 21
6-K
Report of Foreign Private Issuer
12 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Institutional ownership, Q2 2022
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 1 |
Closed positions | 1 |
Increased positions | 2 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 197.95 mm |
Total shares | 82.49 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Yang Weiguang | 82.47 mm | $197.92 mm |
Renaissance Technologies | 16.50 k | $21.00 k |
UBS UBS Group AG - Registered Shares | 6.28 k | $8.00 k |
Captrust Financial Advisors | 696.00 | $1.00 k |
Blue Bell Private Wealth Management | 50.00 | $0.00 |
Proequities | 0.00 | $0.00 |
News
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
23 Jan 23
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
4 Jan 23
Zhongchao Inc. Announces Drug Distributorship In China Of Indian Generic Drugs Of Natco Pharma Limited
4 Jan 23
Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market
3 Nov 22
Press releases
Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China
31 Jan 23
Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment
19 Jan 23
Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma Limited
4 Jan 23
Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform
5 Dec 22
Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market
3 Nov 22